Regulators place hold on ViaCell clinical trial
22nd Sep 2005, 15:30 GMT
The U.S. Food and Drug Administration has placed a clinical hold on ViaCell Inc.'s clinical trial for an umbilical cord blood stem cell-transplantation treatment.
Latest news from bizjournals.com Health Care:Pharmaceuticals headlines:
- United BioSource makes 10th buy, looks for more
- Nonprofits starting to invest in drug companies
- Accentia making changes to its business formula, market focus
- GSK terminates agreement for Genaera frog product
- Gladstone and Merck team to bring drugs to market
- Abbott expects to double vascular business sales
- Mayo to shut down drug-testing unit
- MIT, Dana-Farber win major cancer grants
- Service Bancorp chair resigns
- Introgen strikes nanotech deal with M.D. Anderson